欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Azotobacter vinelandii tRNA (mo5U34)-methyltransferase CSB-YP506999DPY
CSB-EP506999DPY
CSB-BP506999DPY
CSB-MP506999DPY
CSB-EP506999DPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azotobacter vinelandii Na (+)-translocating NADH-quinone reductase subunit E, partial CSB-YP507000DPY1
CSB-EP507000DPY1
CSB-BP507000DPY1
CSB-MP507000DPY1
CSB-EP507000DPY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azotobacter vinelandii Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP507001DPY
CSB-EP507001DPY
CSB-BP507001DPY
CSB-MP507001DPY
CSB-EP507001DPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azotobacter vinelandii NADPH-dependent 7-cyano-7-deazaguanine reductase (queF) CSB-YP507002DPY
CSB-EP507002DPY
CSB-BP507002DPY
CSB-MP507002DPY
CSB-EP507002DPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azotobacter vinelandii Integration host factor subunit beta (ihfB) CSB-YP507003DPY
CSB-EP507003DPY
CSB-BP507003DPY
CSB-MP507003DPY
CSB-EP507003DPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azotobacter vinelandii 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA) CSB-YP507004DPY
CSB-EP507004DPY
CSB-BP507004DPY
CSB-MP507004DPY
CSB-EP507004DPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azotobacter vinelandii Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (lpxA) CSB-YP507005DPY
CSB-EP507005DPY
CSB-BP507005DPY
CSB-MP507005DPY
CSB-EP507005DPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurihydrogenibium azorense NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP507006FPO1
CSB-EP507006FPO1
CSB-BP507006FPO1
CSB-MP507006FPO1
CSB-EP507006FPO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus UPF0344 protein BCA_1194 (BCA_1194), partial CSB-YP507007BQK1
CSB-EP507007BQK1
CSB-BP507007BQK1
CSB-MP507007BQK1
CSB-EP507007BQK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus UPF0477 protein BCA_1270 (BCA_1270) CSB-YP507008BQK
CSB-EP507008BQK
CSB-BP507008BQK
CSB-MP507008BQK
CSB-EP507008BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus 2-oxoglutarate dehydrogenase E1 component (odhA), partial CSB-YP507009BQK
CSB-EP507009BQK
CSB-BP507009BQK
CSB-MP507009BQK
CSB-EP507009BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus Lactate utilization protein B (lutB) CSB-YP507010BQK
CSB-EP507010BQK
CSB-BP507010BQK
CSB-MP507010BQK
CSB-EP507010BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus UPF0180 protein BCA_1448 (BCA_1448) CSB-YP507011BQK
CSB-EP507011BQK
CSB-BP507011BQK
CSB-MP507011BQK
CSB-EP507011BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP507012BQK
CSB-EP507012BQK
CSB-BP507012BQK
CSB-MP507012BQK
CSB-EP507012BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus Imidazole glycerol phosphate synthase subunit HisH (hisH) CSB-YP507013BQK
CSB-EP507013BQK
CSB-BP507013BQK
CSB-MP507013BQK
CSB-EP507013BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus Cytidylate kinase (cmk) CSB-YP507014BQK
CSB-EP507014BQK
CSB-BP507014BQK
CSB-MP507014BQK
CSB-EP507014BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus Methylglyoxal synthase (mgsA) CSB-YP507015BQK
CSB-BP507015BQK
CSB-MP507015BQK
CSB-EP507015BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus Small, acid-soluble spore protein tlp (tlp) CSB-YP507016BQK
CSB-EP507016BQK
CSB-BP507016BQK
CSB-MP507016BQK
CSB-EP507016BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus UPF0154 protein BCA_3779 (BCA_3779), partial CSB-YP507017BQK
CSB-EP507017BQK
CSB-BP507017BQK
CSB-MP507017BQK
CSB-EP507017BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus Xanthine phosphoribosyltransferase (xpt) CSB-YP507018BQK
CSB-EP507018BQK
CSB-BP507018BQK
CSB-MP507018BQK
CSB-EP507018BQK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×